4.7 Article

Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in male mice

Journal

JOURNAL OF NANOBIOTECHNOLOGY
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12951-022-01291-2

Keywords

Magnetic resonance imaging; Contrast agents; Iron oxide nanoparticles; Reversible toxicities; Reproductive system

Funding

  1. National Natural Science Foundation of China [82072055, 81801831, 22007006]
  2. Key Project of Provincial Natural Science Research Project of Anhui Colleges [KJ2019A0278]
  3. Supporting Projects for Innovative Leading Talents [T000529]
  4. Distinguished Young Scholar of Anhui Colleges [gxyqZD2019018]
  5. Anhui Provincial Institute of Translational Medicine [2017ZHYX02, ZHYX2020A003]
  6. Taishan Scholars Construction Engineering [tsqn201909144]
  7. Special Project of Central Government for Local Science and Technology Development of Shandong Province [YDZX20203700001291]
  8. Fundamental Research Funds for the Central Universities [WK9110000062]
  9. Natural Science Foundation of Anhui Province [1808085MB38]

Ask authors/readers for more resources

This study aimed to evaluate the effects of iron oxide nanoparticles (IONPs) on the male reproductive system of mice. The results showed that IONPs did not affect the major organs, but caused damage to Sertoli cells in the blood-testis barrier (BTB) at a relatively high concentration. This led to a temporary reduction in sperm quantity and quality, which was attributed to increased oxidative stress and apoptotic activity in the epididymis. However, these effects were reversible and returned to normal within 14 days after injection of IONPs.
Iron oxide nanoparticles (IONPs)-based contrast agents are widely used for T-2-weighted magnetic resonance imaging (MRI) in clinical diagnosis, highlighting the necessity and importance to evaluate their potential systematic toxicities. Although a few previous studies have documented the toxicity concerns of IONPs to major organs, limited data are available on the potential reproductive toxicity caused by IONPs, especially when administrated via intravenous injection to mimic clinical use of MRI contrast agents. Our study aimed to determine whether exposure to IONPs would affect male reproductive system and cause other related health concerns in ICR mice. The mice were intravenously injected with different concentrations IONPs once followed by routine toxicity tests of major organs and a series of reproductive function-related analyses at different timepoints. As a result, most of the contrast agents were captured by reticuloendothelial system (RES) organs such as liver and spleen, while IONPs have not presented adverse effects on the normal function of these major organs. In contrast, although IONPs were not able to enter testis through the blood testicular barrier (BTB), and they have not obviously impaired the overall testicular function or altered the serum sex hormones levels, IONPs exposure could damage Sertoli cells in BTB especially at a relative high concentration. Moreover, IONPs administration led to a short-term reduction in the quantity and quality of sperms in a dose-dependent manner, which might be attributed to the increase of oxidative stress and apoptotic activity in epididymis. However, the semen parameters have gradually returned to the normal range within 14 days after the initial injection of IONPs. Collectively, these results demonstrated that IONPs could cause reversible damage to the reproductive system of male mice without affecting the main organs, providing new guidance for the clinical application of IONPs as T-2-MRI contrast agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available